Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 29:7:58.
doi: 10.1186/1746-1596-7-58.

HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma

Affiliations

HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma

Leos Kren et al. Diagn Pathol. .

Abstract

Background: Renal cell carcinoma (RCC) is characterized by its resistance to radiotherapy and/or chemotherapy. On the other hand, it is an immunogenic tumor - it is able to stimulate antitumor responses. A prognostic significance of HLA-G expression by neoplastic cells in RCC is not well characterized; significance HLA-E expression in RCC is not characterized at all.

Methods: In our study, we evaluated the expression of HLA-G and HLA-E specific mRNA transcripts produced by neoplastic cells in 38 cases of RCC and in 10 samples of normal kidney parenchyma. The results were statistically correlated with various clinico-pathological parameters.

Results: We confirmed that HLA-G is downregulated in normal kidney tissue; if it is up-regulated in RCC, then it is connected to worse prognosis. On the other hand, HLA-E mRNA transcripts were present in both normal kidney tissue and RCC and their increasing concentrations counterintuitively carried better prognosis, more favorable pT stage and lower nuclear Fuhrmann's grade.

Conclusion: Considering the fact that there is known aberrant activation of HLA-G and HLA-E expression by interferons, identification of HLA-G and HLA-E status could contribute to better selection of RCC patients who could possibly benefit from more tailored neoadjuvant biological/immunological therapy. Thus, these molecules could represent useful prognostic biomarkers in RCC, and the expression of both these molecules in RCC deserves further study. THE VIRTUAL: Slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7383071387016614.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of HLA-G expression levels in RCC tissue and non-tumoral renal parenchyma (p = 0.0058, Mann–Whitney test).
Figure 2
Figure 2
Comparison of HLA-E expression levels in RCC tissue and non-tumoral renal parenchyma (p = 0.126, Mann–Whitney test).
Figure 3
Figure 3
Relapse-free survival of RCC patients based on the HLA-G expression (cut off = 75th percentile of HLA-G expression levels in RCC tissue; p = 0,0401, Long-rank test).
Figure 4
Figure 4
Relapse-free survival of RCC patients based on the HLA-E expression (cut off = 25th percentile of HLA-E expression levels in RCC tissue; p = 0,0115, Long-rank test).
Figure 5
Figure 5
HLA-E expression levels in RCC of different pT stage (p = 0.041, Mann–Whitney test).
Figure 6
Figure 6
Correlation of HLA-E expression with Fuhrmann’s grade of RCC (p = 0.0423, Kruskal-Wallis test).
Figure 7
Figure 7
Positivity of RCC for the HLA-G, immunohistochemistry, DAB method, clone MEM-G/1, Exbio Prague. Analysed by Olympus BX45 microscope equipped with Olympus DP50 digital camera. Olympus Viewfinder Lite™software was used to acquire and process the image, 400×.
Figure 8
Figure 8
Positivity of RCC for the HLA-E, immunohistochemistry, DAB method, clone MEM-E/02, Exbio Prague. Analysed by Olympus BX45 microscope equipped with Olympus DP50 digital camera. Olympus Viewfinder Lite™software was used to acquire and process the image, 400×.

References

    1. Kovats S, Main EK, Librach C. et al.A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248:220–223. doi: 10.1126/science.2326636. - DOI - PubMed
    1. King A, Allan DS, Bowen M. et al.HLA-E is expressedon trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol. 2000;30:1623–1631. doi: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M. - DOI - PubMed
    1. Pradhan D, Kakkar N, Bal A, Singh SK, Joshi K. Sub-typing of renal cell tumours; contribution of ancillary techniques. Diagn Pathol. 2009;4:21. doi: 10.1186/1746-1596-4-21. - DOI - PMC - PubMed
    1. Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P. Evaluation of neuroendocrine markers in renal cell carcinoma. Diagn Pathol. 2010;5:28. doi: 10.1186/1746-1596-5-28. - DOI - PMC - PubMed
    1. Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED. Tissue microarrays: one size does not fit all. Diagn Pathol. 2010;5:48. doi: 10.1186/1746-1596-5-48. - DOI - PMC - PubMed

Publication types

MeSH terms